Related references
Note: Only part of the references are listed.Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection
Joy E. Chiu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts
Bumduuren Tuvshintulga et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Current and Future Spatiotemporal Patterns of Lyme Disease Reporting in the Northeastern United States
Donal Bisanzio et al.
JAMA NETWORK OPEN (2020)
Insights From the Geographic Spread of the Lyme Disease Epidemic
Taylor Eddens et al.
CLINICAL INFECTIOUS DISEASES (2019)
Mitochondrial dynamics in parasitic protists
Lubos Voleman et al.
PLOS PATHOGENS (2019)
Evidence for vesicle-mediated antigen export by the human pathogen Babesia microti
Jose Thekkiniath et al.
LIFE SCIENCE ALLIANCE (2019)
BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection
Jose Thekkiniath et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome b That Are Transmissible through Mosquitoes
Lynn D. Blake et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone
Lauren A. Lawres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes
Christopher D. Goodman et al.
SCIENCE (2016)
A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse
Jacob E. Lemieux et al.
NATURE MICROBIOLOGY (2016)
Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions
Joana C. Silva et al.
SCIENTIFIC REPORTS (2016)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
Prevalence of Anaplasma phagocytophilum and Babesia microti in Ixodes scapularis from a Newly Established Lyme Disease Endemic Area, the Thousand Islands Region of Ontario, Canada
Lisa Werden et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2015)
Babesia microti: an unusual travel-related disease
Elodie Poisnel et al.
BMC INFECTIOUS DISEASES (2013)
Antimalarial pharmacology and therapeutics of atovaquone
Gemma L. Nixon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Whole Genome Mapping and Re-Organization of the Nuclear and Mitochondrial Genomes of Babesia microti Isolates
Emmanuel Cornillot et al.
PLOS ONE (2013)
Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein Expression
Nicholas Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
CURRENT CONCEPTS Human Babesiosis
Edouard Vannier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti†
Emmanuel Cornillot et al.
NUCLEIC ACIDS RESEARCH (2012)
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Heather J. Painter et al.
NATURE (2007)
The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of America
Gary P. Wormser et al.
CLINICAL INFECTIOUS DISEASES (2006)
Anaplasma phagocytophilum, Babesia microti, and Borrelia burgdorferi in Ixodes scapularis, southern coastal Maine
MS Holman et al.
EMERGING INFECTIOUS DISEASES (2004)
Atovaquone and azithromycin for the treatment of babesiosis.
PJ Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
M Korsinczky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Atovaquone resistance in malaria parasites
AB Vaidya et al.
DRUG RESISTANCE UPDATES (2000)
Share Paper
